The global antibody production market is expected to reach a value of USD
22.6 billion by 2025, according to a new report by Grand View Research, Inc.
Increasing demand for therapeutic antibodies including monoclonal and
polyclonal antibodies is a major factor that drives growth of the market during
forecast period. Antibodies are the dominant biopharmaceuticals that
specifically target the abnormal cells. Thus, many pharmaceuticals and
biotechnology companies have begun to focus on the development of advanced
antibodies for the treatment of chronic diseases such as cancer, rheumatic
heart disease, and arthritis.
 |
North America antibody production market share, by end-use,
2016 (%)
|
Patent expiry of several blockbuster monoclonal antibodies in the near
future, is another major factor supporting the growth of the antibody production
market. Several antibodies such as Avastin, Herceptin, and Mabthera are going
to lose their patents in a few years. For instance, the patent of Herceptin
(trastuzumab) expired in Europe in July 2014 and will expire in the U.S. in
June 2019. Many companies such as Amgen Inc., Synthon, Biocon, and Pfizer Inc.
are developing biosimilar for trastuzumab, which is expected to propel the
demand for antibody production products.
In depth research report on Antibody Production Market
Further key findings from the study suggest:
·
Downstream
processing was the largest revenue-grossing segment of the antibody production
market in 2016. It is also expected to exhibit the highest CAGR during the
forecast period, owing to large application of chromatography devices and
resins in downstream processing
·
The monoclonal
antibody segment was leading in 2016, due to its higher demand in treatment of
chronic diseases including cancer, blood disorders, and growth hormone
deficiency
·
The
pharmaceutical and biotechnology companies segment dominated the overall market
in terms of revenue in 2016, owing to the large production of therapeutic
antibodies and high investment in R&D by companies for drug development
·
North America
was the largest revenue-generating region of the market in the year 2016. This
region is expected to maintain its position during the forecast period because
of the presence of several leading biopharmaceuticals and biotechnology
companies in this region
·
Asia Pacific
region is projected to be the fastest-growing segment over the study period,
due to rapidly booming biotechnology industry and comparatively less stringent
regulations for biologics development in APAC region
·
Some of the
key players include GE Healthcare; Thermo Fisher Scientific, Inc.; Sartorius
AG; Merck KGaA; Pall Corp.; Eppendorf AG; Cellab GmbH; INTEGRA Biosciences AG;
and FiberCell Systems Inc.
Grand View Research has segmented the antibody production market on the
basis of type, process, end-use, and region:
Antibody Production Type Outlook (Revenue, USD
Million; 2014 - 2025)
·
Polyclonal
antibody
·
Monoclonal
antibody
·
Murine
·
Chimeric
·
Humanized
Antibody Production Process Outlook (Revenue,
USD Million; 2014 - 2025)
·
Upstream
processing
o
Bioreactors
o
Largescale
bioreactors
o
Single-use
bioreactors
o
Consumables
o
Media
o
Buffers and
reagents
·
Downstream
processing
o
Chromatography
systems
o
Chromatography
resins
·
Filtration
o
Filtration
systems
o
Filtration
consumables and accessories
Antibody Production End-Use Outlook (Revenue,
USD Million; 2014 - 2025)
·
Pharmaceutical
and biotechnology companies
·
Research
laboratories
·
Others
Antibody Production Regional Outlook (Revenue,
USD Million; 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For more
market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment